NLRP3 and colorectal carcinoma: To uncover the underlying mechanisms of how KD inhibits CRC growth, the authors investigated the role of two identified KD-inhibited factors, IL-17-producing immune cells and NLRP3 inflammasome, in AOM/DSS models with Rag1−/− mice and NLRP3-deficient bone marrow chimeric mice, respectively.